Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Ovarian Neoplasms

  Free Subscription


Articles published in Am J Obstet Gynecol

Retrieve available abstracts of 34 articles:
HTML format
Text format



Single Articles


    July 2019
  1. GENTRY-MAHARAJ A, Burnell M, Dilley J, Ryan A, et al
    Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses.
    Am J Obstet Gynecol. 2019 Jul 24. pii: S0002-9378(19)30936.
    PubMed     Text format     Abstract available


  2. TARNEY CM, Wang G, Bateman NW, Conrads KA, et al
    Biomarker Panel for Early Detection of Endometrial Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Am J Obstet Gynecol. 2019 Jul 4. pii: S0002-9378(19)30769.
    PubMed     Text format     Abstract available


    June 2019
  3. GOCKLEY A, Melamed A, Cronin A, Bookman MA, et al
    Outcomes of secondary cytoreductive surgery for patients with platinum-sensitive recurrent ovarian cancer.
    Am J Obstet Gynecol. 2019 Jun 14. pii: S0002-9378(19)30773.
    PubMed     Text format     Abstract available


    May 2019
  4. UCCELLA S, Nero C, Vizza E, Vargiu V, et al
    Sentinel-Node Biopsy in Early Stage Ovarian Cancer: Preliminary Results of a Prospective Multicentre Study (SELLY).
    Am J Obstet Gynecol. 2019 May 10. pii: S0002-9378(19)30660.
    PubMed     Text format     Abstract available


  5. MANNING-GEIST BL, Hicks-Courant K, Gockley AA, Clark RM, et al
    A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome.
    Am J Obstet Gynecol. 2019 May 10. pii: S0002-9378(19)30661.
    PubMed     Text format     Abstract available


    April 2019
  6. SUIDAN RS, He W, Sun CC, Zhao H, et al
    Total and out-of-pocket costs of different primary management strategies in ovarian cancer.
    Am J Obstet Gynecol. 2019 Apr 6. pii: S0002-9378(19)30565.
    PubMed     Text format     Abstract available


    February 2019
  7. CHAM S, Chen L, St Clair CM, Hou JY, et al
    Development and Validation of a Risk-Calculator for Adverse Perioperative Outcomes for Women with Ovarian Cancer.
    Am J Obstet Gynecol. 2019 Feb 13. pii: S0002-9378(19)30360.
    PubMed     Text format     Abstract available


    September 2018
  8. ACKROYD SA, Brown J, Houck K, Chu C, et al
    A preoperative risk score to predict red blood cell transfusion in patients undergoing hysterectomy for ovarian cancer.
    Am J Obstet Gynecol. 2018 Sep 18. pii: S0002-9378(18)30759.
    PubMed     Text format     Abstract available


    August 2018
  9. TAMAUCHI S, Kajiyama H, Yoshihara M, Ikeda Y, et al
    Reproductive outcomes of 105 malignant ovarian germ cell tumor survivors: a multicenter study.
    Am J Obstet Gynecol. 2018 Aug 4. pii: S0002-9378(18)30608.
    PubMed     Text format     Abstract available


    May 2018
  10. HANLEY GE, Kwon JS, Finlayson SJ, Huntsman DG, et al
    Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: A cohort study from British Columbia, Canada.
    Am J Obstet Gynecol. 2018 May 28. pii: S0002-9378(18)30429.
    PubMed     Text format     Abstract available


  11. GEMER O, Segev Y, Helpman L, Hag-Yahia N, et al
    Is there a survival advantage in diagnosing endometrial cancer in asymptomatic postmenopausal patients? An Israeli Gynecology Oncology Group study.
    Am J Obstet Gynecol. 2018 May 21. pii: S0002-9378(18)30408.
    PubMed     Text format     Abstract available


    April 2018
  12. PATEL S, Legood R, Evans DG, Turnbull C, et al
    Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women.
    Am J Obstet Gynecol. 2018;218:431.
    PubMed     Text format     Abstract available


    March 2018
  13. ADELMAN MR, Sharp HT
    Ovarian conservation vs removal at the time of benign hysterectomy.
    Am J Obstet Gynecol. 2018;218:269-279.
    PubMed     Text format     Abstract available


    January 2018
  14. BOAC BM, Xiong Y, Apte SM, Wenham RM, et al
    Adherence to practice guidelines is associated with reduced referral times for patients with ovarian cancer.
    Am J Obstet Gynecol. 2018 Jan 15. pii: S0002-9378(18)30018.
    PubMed     Text format     Abstract available


  15. GOETSCH MF
    Management of sexuality, intimacy, and menopause symptoms after ovarian cancer.
    Am J Obstet Gynecol. 2018 Jan 4. pii: S0002-9378(18)30001.
    PubMed     Text format    


    November 2017
  16. MANCHANDA R, Patel S, Antoniou AC, Levy-Lahad E, et al
    Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry.
    Am J Obstet Gynecol. 2017;217:578.
    PubMed     Text format     Abstract available


    October 2017
  17. ALMASI-HASHIANI A, Ayubi E, Safiri S
    Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer: Methodological issues.
    Am J Obstet Gynecol. 2017 Oct 17. pii: S0002-9378(17)31203.
    PubMed     Text format    


  18. BISHOP EA, Java JJ, Moore KN, Spirtos NM, et al
    Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: A NRG/Gynecologic Oncology Group Study.
    Am J Obstet Gynecol. 2017 Oct 13. pii: S0002-9378(17)31189.
    PubMed     Text format     Abstract available


    August 2017
  19. RUIZ MP, Huang Y, Hou JY, Tergas AI, et al
    All-Cause Mortality in Young Women with Endometrial Cancer Receiving Progesterone Therapy.
    Am J Obstet Gynecol. 2017 Aug 24. pii: S0002-9378(17)30942.
    PubMed     Text format     Abstract available


    July 2017
  20. ABRAMOWICZ JS, Timmerman D
    Ovarian mass-differentiating benign from malignant. The value of the International Ovarian Tumor Analysis (IOTA) ultrasound rules.
    Am J Obstet Gynecol. 2017 Jul 20. pii: S0002-9378(17)30861.
    PubMed     Text format     Abstract available


  21. ANTOSH DD, High R, Brown HW, Oliphant SS, et al
    Feasibility of Prophylactic Salpingectomy During Vaginal Hysterectomy.
    Am J Obstet Gynecol. 2017 Jul 19. pii: S0002-9378(17)30859.
    PubMed     Text format     Abstract available


  22. MARGOLIS B, Chen L, Accordino MK, Hillyer GC, et al
    Trends in End of Life Care and Healthcare Spending in Women with Uterine Cancer.
    Am J Obstet Gynecol. 2017 Jul 11. pii: S0002-9378(17)30848.
    PubMed     Text format     Abstract available


    June 2017
  23. MATSUO K, Machida H, Horowitz MP, Shahzad MMK, et al
    Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer.
    Am J Obstet Gynecol. 2017 Jun 27. pii: S0002-9378(17)30788.
    PubMed     Text format     Abstract available


  24. CADISH LA, Shepherd JP, Barber EL, Ridgeway B, et al
    Risks and benefits of opportunistic salpingectomy during vaginal hysterectomy : A decision analysis.
    Am J Obstet Gynecol. 2017 Jun 12. pii: S0002-9378(17)30743.
    PubMed     Text format     Abstract available


  25. MOULTON L, Jernigan AM, Carr C, Freeman L, et al
    Single Port Laparoscopy in Gynecologic Oncology: Seven Years of Experience at a Single Institution.
    Am J Obstet Gynecol. 2017 Jun 12. pii: S0002-9378(17)30744.
    PubMed     Text format     Abstract available


    May 2017
  26. PETRILLO M, Marchetti C, De Leo R, Musella A, et al
    Brca Mutational Status, Initial Disease Presentation and Clinical Outcome in High-Grade Serous Advanced Ovarian Cancer: A Multicenter Study.
    Am J Obstet Gynecol. 2017 May 23. pii: S0002-9378(17)30647.
    PubMed     Text format     Abstract available


    April 2017
  27. WHICKER M, Black J, Altwerger G, Menderes G, et al
    Management of Sexuality, Intimacy, and Menopause Symptoms (SIMS) in Ovarian Cancer Patients: Expert Review.
    Am J Obstet Gynecol. 2017 Apr 11. pii: S0002-9378(17)30513.
    PubMed     Text format     Abstract available


  28. RING KL, Garcia C, Thomas MH, Modesitt SC, et al
    Current and Future Role of Genetic Screening in Gynecologic Malignancies.
    Am J Obstet Gynecol. 2017 Apr 11. pii: S0002-9378(17)30512.
    PubMed     Text format     Abstract available


    March 2017
  29. CHEN PH
    The yolky thecoma.
    Am J Obstet Gynecol. 2017;216:318.
    PubMed     Text format    


    February 2017
  30. MOORE RG, Plante B, Hartnett E, Mitchel J, et al
    Assessment of serum HE4 levels throughout the normal menstrual cycle.
    Am J Obstet Gynecol. 2017 Feb 22. pii: S0002-9378(17)30320.
    PubMed     Text format     Abstract available


    January 2017
  31. STANHISER J, Chagin K, Jelovsek JE
    A Model to Predict Risk of Blood Transfusion After Gynecologic Surgery.
    Am J Obstet Gynecol. 2017 Jan 16. pii: S0002-9378(17)30104.
    PubMed     Text format     Abstract available


    October 2016
  32. HANLEY GE, McAlpine JN, Pearce CL, Miller D, et al
    The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States.
    Am J Obstet Gynecol. 2016 Oct 31. pii: S0002-9378(16)30971.
    PubMed     Text format     Abstract available


    July 2016
  33. BINDER PS, Peipert JF, Kallogjeri D, Brooks RA, et al
    Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
    Am J Obstet Gynecol. 2016 Jul 22. pii: S0002-9378(16)30470.
    PubMed     Text format     Abstract available


  34. FRANCHI D, Boveri S, Radice D, Portuesi R, et al
    Ultrasonographic diagnosis and longitudinal follow-up of recurrences after conservative surgery for Borderline Ovarian tumors.
    Am J Obstet Gynecol. 2016 Jul 18. pii: S0002-9378(16)30458.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: